Filing Details
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2009-03-18 17:57:58
- Reporting Period:
- 2009-03-16
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 932352 | Urigen Pharmaceuticals Inc. | UGRP.OB | () |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1407236 | E Martin Shmagin | C/O Urigen Pharmaceuticals, Inc. 27 Maiden Lane San Francisco CA 94108 | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $.001 Par Value | Acquisiton | 2009-03-16 | 1,000 | $0.09 | 3,136,073 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
